Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts

Clinical trial NCT05799157 · COMPLETED

Trial details

NCT number: NCT05799157
Sponsor: Veradermics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Verruca Vulgaris Warts Common Wart

Start date: 2023-02-28
Primary completion: 2025-02-25
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.